
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
By Sriparna Roy (Reuters) -Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S. regulators saying that it sees a pathway to resolving issues with the FDA, sending shares up nearly 19% in early …